ヘルスケア分析市場規模、シェア、動向、2030年までの世界予測

ヘルスケア分析市場は2026年に697億4,000万米ドル規模となり、2031年には2,132億7,000万米ドルへと成長し、予測期間中の年平均成長率（CAGR）は25.1%に達するとMarketsandMarketsでは予測しています。

電子カルテ（EHR）の普及が、ヘルスケア分析市場の成長を牽引しています。北米では、開業医や連邦政府以外の急性期病院がEHRシステムを導入しています。また、経済・臨床医療のための医療情報技術法（HITE-ECHA）に基づき、EHRシステム導入を支援する政府によるインセンティブも提供されています。この市場を牽引する要因としては、人工知能の進歩、価値に基づく医療システム、リアルワールドデータに加え、医療保険者、医療提供者、ライフサイエンス企業、回復期医療機関によるヘルスケア分析サービスへの関心の高まりなどが挙げられます。

調査概要

本レポートは、ヘルスケア分析市場を分析します。コンポーネント、タイプ、アプリケーション、エンドユーザー、地域といった様々な市場セグメントに基づき、市場規模と将来の成長可能性を推定することを目的としています。また、主要企業の競合分析に加え、企業プロファイル、製品ラインナップ、最近の動向、主要な市場戦略についても解説します。

本レポートを購入する理由

本レポートは、ヘルスケア分析市場および各サブセグメントの収益予測に関する最も正確な情報を提供することで、市場リーダーや新規参入企業を支援します。関係者は、本レポートを通じて競争環境を理解し、より的確な事業展開と適切な市場参入戦略の策定に向けた洞察を得ることができます。さらに、市場の動向を把握し、主要な市場推進要因、阻害要因、課題、機会に関する情報を提供することで、関係者の意思決定を支援します。

本レポートは、以下のポイントに関する洞察を提供します。

医療分析市場の成長に影響を与える主要な推進要因（電子カルテ導入を促進する政府の取り組み、スタートアップ企業へのベンチャーキャピタル投資の増加、医療費削減の必要性、リアルワールドエビデンスへの注目の高まり、遠隔医療および遠隔患者モニタリングの台頭、規制遵守への注目の高まり）、阻害要因（分析ソリューションの高コスト、データ漏洩への懸念の高まり）、機会（価値に基づく医療への注目の高まり、医療における分析の利用拡大、患者登録数の増加、ソーシャルメディアおよびデジタルヘルス技術の出現）、そして課題（データの不正確性および一貫性に関する懸念、発展途上国における医療分析ソリューション導入への抵抗、医療記録管理の不備、熟練人材の不足）を分析します。

• 製品開発／イノベーション：医療分析市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な洞察を提供します。
• 市場開発：有望な市場に関する包括的な情報を提供し、様々な地域における医療分析市場を分析します。
• 市場の多様化：ヘルスケア分析市場における新製品・サービス、未開拓地域、最新動向、投資に関する包括的な情報
• 競合分析：ヘルスケア分析市場における主要企業（Merative（米国）、Optum, Inc.（米国）、SAS Institute Inc.（米国）、Oracle（米国）、Citiustech Inc（米国）、Inovalon（米国）、McKesson Corporation（米国）、MedeAnalytics, Inc.（米国）、Cotiviti, Inc.（米国）、Exlservice Holdings, Inc.（米国）、Wipro（インド）など）の市場シェア、成長戦略、サービス提供内容に関する詳細な分析

Report Description

The report “Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), End User (Payer, Hospital, ACO, ASC), AI, Market Insights, Trends – Forecast to 2031” is projected to reach USD 213.27 billion by 2031 from USD 69.74 billion in 2026, at a CAGR of 25.1% from 2026-2031.

“By application, clinical analytics segment is expected to witness the highest growth during the forecast period.”

Based on application,  the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics, and population health analytics. The clinical analytics segment is growing at the fastest rate during the forecast period driven by increasing adoption of AI-enabled clinical decision support, predictive risk modeling, and real-time patient insights to improve care outcomes, reduce readmissions, and support value-based care initiatives across providers and health system.

By component, services segment to witness the highest growth during the forecast period.”

Based on component,  the healthcare analytics market is segmented into software and services. The clinical analytics segment is growing at the fastest rate during the forecast period driven by rising demand for implementation, system integration, data management, and advanced analytics consulting as healthcare organizations seek to deploy complex AI- and cloud-based analytics platforms while ensuring interoperability, regulatory compliance, and faster time to value.

“APAC is estimated to register the highest CAGR during the forecast period.”

The healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in Asia Pacific is projected to register the highest CAGR rate during the forecast period. This is driven by rapid EHR penetration, cloud-native deployments, and AI/ML adoption across providers and payers. Increasing use of population health analytics, real-world evidence, and predictive modeling, supported by government-led digital health programs and improving data interoperability standards, is accelerating large-scale analytics implementation across China, India, Japan, and Southeast Asia.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

• By Company Type: Tier 1 – 45%, Tier 2 – 35%, and Tier 20%
• By Designation: C-level Executives – 50%, Directors – 30%, and Others – 20%
• By Region: North America– 40%, Europe – 35%, Asia Pacific– 20% and RoW- 5%

Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.

The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The report analyses the healthcare analytics market. It aims to estimate the market size and future growth potential of various market segments based on component, type, application, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (favorable government initiatives for electronic health record adoption, growing venture capital investments in startups, need to reduce healthcare costs, increasing focus on real-world evidence, rise of telemedicine and remote patient monitoring, growing focus on regulatory compliance), restraints (hiigh cost of analytics solutions, growing concerns about data breach), opportunities (increasing focus on value-based medicines, growing use of analytics in healthcare, rising number of patient registeries, emergence of social media and digital health technologies), and challenges (concerns regarding inaccurate and inconsistent data, reluctance to adopt healthcare analytics solutions in developing countries, lack of maintenance of medical records, shortage of skilled personnel) influencing the growth of the healthcare analytics market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
• Market Development: Comprehensive information about lucrative markets, the report analyses the healthcare analytics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), among others in the healthcare analytics market

Table of Contents

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 47
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 47
1.3.2 INCLUSIONS AND EXCLUSIONS 48
1.3.3 YEARS CONSIDERED 48
1.4 CURRENCY CONSIDERED 48
1.5 STAKEHOLDERS 49
1.6 SUMMARY OF CHANGES 50
2 EXECUTIVE SUMMARY 51
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 51
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 52
2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE ANALYTICS MARKET 53
2.4 HIGH-GROWTH SEGMENTS 54
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 55
3 PREMIUM INSIGHTS 56
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE ANALYTICS MARKET 56
3.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER AND COUNTRY 57
3.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY 58
4 MARKET OVERVIEW 59
4.1 INTRODUCTION 59
4.2 MARKET DYNAMICS 59
4.2.1 DRIVERS 60
4.2.1.1 Favorable government initiatives for electronic health record adoption 60
4.2.1.2 Growing venture capital investments in startups 61
4.2.1.3 Need to reduce healthcare costs 61
4.2.1.4 Increasing focus on real-world evidence 62
4.2.1.5 Rise of telemedicine and remote patient monitoring 63
4.2.1.6 Growing focus on regulatory compliance 63
4.2.2 RESTRAINTS 64
4.2.2.1 High cost of analytics solutions 64
4.2.2.2 Growing concerns about data breaches 65
4.2.3 OPPORTUNITIES 67
4.2.3.1 Increasing focus on value-based medicines 67
4.2.3.2 Growing use of analytics in healthcare 68
4.2.3.3 Rising number of patient registries 68
4.2.3.4 Emergence of social media and digital health technologies 69
4.2.4 CHALLENGES 69
4.2.4.1 Concerns regarding inaccurate and inconsistent data 69
4.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries 70
4.2.4.3 Lack of maintenance of medical records 70
4.2.4.4 Shortage of skilled personnel 71
4.3 UNMET NEEDS AND WHITE SPACES 72
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 72
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 73
5 INDUSTRY TRENDS 75
5.1 PORTER’S FIVE FORCES ANALYSIS 75
5.2 MACROECONOMIC INDICATORS 77
5.2.1 GDP TRENDS AND FORECAST 78
5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 78
5.3 VALUE CHAIN ANALYSIS 79
5.4 ECOSYSTEM ANALYSIS 80
5.5 PRICING ANALYSIS 82
5.5.1 INDICATIVE PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 82
5.5.2 INDICATIVE PRICING, BY REGION 83
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 84
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 85
5.8 INVESTMENT AND FUNDING SCENARIO 85
5.9 CASE STUDY ANALYSIS 86
5.10 IMPACT OF 2025 US TARIFF – HEALTHCARE ANALYTICS MARKET 88
5.10.1 KEY TARIFF RATES 89
5.10.2 PRICE IMPACT ANALYSIS 90
5.10.3 IMPACT ON COUNTRIES/REGIONS 90
5.10.3.1 US 90
5.10.3.2 Europe 91
5.10.3.3 Asia Pacific 91
5.10.4 IMPACT ON END-USE INDUSTRY 91
5.10.4.1 Healthcare providers 91
5.10.4.1.1 Hospitals & health systems 91
5.10.4.1.2 Physician groups & clinics 92
5.10.4.1.3 Ambulatory surgery centers (ASCs) 92
5.10.4.2 Healthcare payers 92
5.10.4.2.1 Private insurance companies 92
5.10.4.2.2 Government payers 92
5.10.4.3 Pharmacies 92
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 93
6.1 TECHNOLOGY ANALYSIS 93
6.1.1 KEY TECHNOLOGIES 93
6.1.1.1 Big data analytics 93
6.1.1.2 Artificial intelligence and machine learning 94
6.1.1.3 Business intelligence tools 94
6.1.2 COMPLEMENTARY TECHNOLOGIES 94
6.1.2.1 Cloud computing and data integration platforms 94
6.1.2.2 Interoperability frameworks and APIs 95
6.1.3 ADJACENT TECHNOLOGIES 95
6.1.3.1 Cloud computing 95
6.1.3.2 Internet of Things 95
6.2 TECHNOLOGY/PRODUCT ROADMAP 96
6.3 PATENT ANALYSIS 97
6.3.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ANALYTICS MARKET 97
6.3.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 98
6.4 FUTURE APPLICATIONS 101
6.4.1 AI-DRIVEN PREDICTIVE ANALYTICS AND CLINICAL DECISION SUPPORT 101
6.4.2 REAL-WORLD EVIDENCE (RWE) AND CLINICAL RESEARCH TRANSFORMATION 101
6.4.3 OPERATIONAL INTELLIGENCE AND HEALTHCARE SYSTEM OPTIMIZATION 101
6.5 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET 101
6.5.1 MARKET POTENTIAL OF AI/GEN AI 102
6.5.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN HEALTHCARE ANALYTICS MARKET 103
6.5.2.1 AI-driven continuous glucose monitoring and diabetes management 103
6.5.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 104
6.5.3.1 Clinical development & decentralized trials 104
6.5.3.2 Digital biomarkers & endpoint innovation 105
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HEALTHCARE ANALYTICS MARKET 105
6.5.4.1 User readiness 105
6.5.4.1.1 User A: Hospitals, clinics & long-term care providers 105
6.5.4.1.2 User B: Pharma and biotech companies 105
6.5.4.2 Impact assessment 105
6.5.4.2.1 User A: Hospitals, clinics & long-term care providers 105
6.5.4.2.1.1 Implementation 105
6.5.4.2.1.2 Impact 106
6.5.4.2.2 User B: Healthcare payers 106
6.5.4.2.2.1 Implementation 106
6.5.4.2.2.2 Impact 106
7 REGULATORY LANDSCAPE 107
7.1 REGIONAL REGULATIONS AND COMPLIANCE 107
7.1.1 GOVERNMENT REGULATIONS 110
7.1.1.1 US 110
7.1.1.2 Europe 110
7.1.1.3 China 110
7.1.1.4 Japan 111
7.1.1.5 India 111
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.3 INDUSTRY STANDARDS 114
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 115
8.1 DECISION-MAKING PROCESS 115
8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 116
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 116
8.2.2 BUYING CRITERIA 117
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 118
8.4 UNMET NEEDS FROM END-USE INDUSTRIES 118
8.4.1 UNMET NEEDS 119
8.4.2 END-USER EXPECTATIONS 120
8.5 MARKET PROFITABILITY 120
9 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 122
9.1 INTRODUCTION 123
9.2 SERVICES 123
9.2.1 MANAGED SERVICES 125
9.2.1.1 Analytics operations 127
9.2.1.1.1 Continuous performance monitoring reshapes managed analytics delivery models 127
9.2.1.2 Infrastructure & cloud management 128
9.2.1.2.1 Cloud-native infrastructure services underpin healthcare analytics scalability 128
9.2.2 PROFESSIONAL SERVICES 129
9.2.2.1 Training & education 131
9.2.2.1.1 Workforce upskilling becomes critical enabler of analytics transformation 131
9.2.2.2 Implementation & integration 132
9.2.2.2.1 Interoperability mandates catalyze complex analytics integration engagements 132
9.2.2.3 Consulting 133
9.2.2.3.1 Strategic data governance consulting unlocks organizational analytics readiness 133
9.2.2.4 Support & maintenance 134
9.2.2.4.1 Post-deployment support sustains long-term analytics performance and compliance 134
9.3 SOFTWARE 135
9.3.1 POINT ANALYTICS SOLUTIONS 137
9.3.1.1 Targeted problem-solving drives rapid adoption of specialized analytics tools 137
9.3.2 ENTERPRISE-WIDE ANALYTICS PLATFORMS 138
9.3.2.1 Unified data platforms enable cross-continuum analytics at enterprise scale 138
10 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL 140
10.1 INTRODUCTION 141
10.2 ON-PREMISES 141
10.3 CLOUD-BASED 142
11 HEALTHCARE ANALYTICS MARKET, BY TYPE 144
11.1 INTRODUCTION 145
11.2 DESCRIPTIVE ANALYTICS 145
11.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET 145
11.3 PREDICTIVE ANALYTICS 147
11.3.1 AI-POWERED RISK MODELS TRANSFORM PROACTIVE CLINICAL AND OPERATIONAL PLANNING 147
11.4 PRESCRIPTIVE ANALYTICS 150
11.4.1 NEXT-BEST-ACTION OPTIMIZATION ELEVATES ANALYTICS FROM INSIGHT TO AUTOMATED INTERVENTION 150
11.5 DIAGNOSTIC ANALYTICS 151
11.5.1 ROOT-CAUSE INTELLIGENCE DRIVES SYSTEMATIC QUALITY AND COST PERFORMANCE IMPROVEMENT 151
12 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 153
12.1 INTRODUCTION 154
12.2 FINANCIAL ANALYTICS 154
12.2.1 CLAIMS ANALYTICS 156
12.2.1.1 Automated claims intelligence reduces revenue leakage and administrative burden 156
12.2.2 REVENUE CYCLE MANAGEMENT 157
12.2.2.1 End-to-end revenue intelligence optimizes margins across care continuum 157
12.2.3 FRAUD, WASTE, & ABUSE ANALYTICS 159
12.2.3.1 AI-powered detection frameworks reduce healthcare fraud and improper payments 159
12.2.4 RISK ADJUSTMENT & PAYMENT INTEGRITY 160
12.2.4.1 Accurate risk coding drives financial sustainability in value-based health plans 160
12.3 CLINICAL ANALYTICS 162
12.3.1 CLINICAL DECISION SUPPORT 164
12.3.1.1 Real-time evidence delivery at point of care transforms clinical outcomes 164
12.3.2 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING 166
12.3.2.1 National quality benchmarks propel data-driven performance accountability 166
12.3.3 MEDICAL IMAGING ANALYTICS 167
12.3.3.1 AI-augmented imaging analysis accelerates diagnostic throughput and accuracy 167
12.3.4 REMOTE PATIENT MONITORING ANALYTICS 168
12.3.4.1 Wearable data integration expands longitudinal analytics beyond clinical walls 168
12.3.5 PRECISION HEALTH ANALYTICS 170
12.3.5.1 Genomic and multi-omics data convergence enables personalized care delivery 170
12.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 171
12.4.1 SUPPLY CHAIN ANALYTICS 173
12.4.1.1 Predictive supply intelligence mitigates healthcare cost and shortage risks 173
12.4.2 WORKFORCE ANALYTICS 174
12.4.2.1 Predictive staffing models address healthcare talent shortages and labor costs 174
12.4.3 STRATEGIC ANALYTICS 175
12.4.3.1 Real-time visibility optimizes patient flow across complex care environments 175
12.4.4 CAPACITY & WORKFLOW ANALYTICS 177
12.4.4.1 Rising adoption of capacity & workflow analytics 177
12.5 POPULATION HEALTH ANALYTICS 177
12.5.1 CHRONIC DISEASE MANAGEMENT 179
12.5.1.1 Implementing predictive analytics for early identification and proactive management of high-risk chronic disease patients 179
12.5.2 PREVENTIVE CARE ANALYTICS 180
12.5.2.1 Screening gap identification drives proactive population wellness interventions 180
12.5.3 VALUE-BASED CARE ANALYTICS 181
12.5.3.1 Total cost of care intelligence enables sustainable value-based contract performance 181
12.5.4 RISK STRATIFICATION 182
12.5.4.1 Predictive scoring models enable precision targeting of high-risk individuals 182

12.6 PATIENT JOURNEY & ENGAGEMENT ANALYTICS 183
12.6.1 PATIENT COMMUNICATION & OUTREACH ANALYTICS 185
12.6.1.1 Multichannel analytics optimizes outreach precision and patient response rates 185
12.6.2 PATIENT ADHERENCE ANALYTICS 186
12.6.2.1 Behavioral data insights drive targeted interventions to improve treatment compliance 186
12.6.3 PATIENT EXPERIENCE ANALYTICS 187
12.6.3.1 Satisfaction intelligence transforms patient-centered care accountability 187
13 HEALTHCARE ANALYTICS MARKET, BY END USER 189
13.1 INTRODUCTION 190
13.2 HEALTHCARE PROVIDERS 190
13.2.1 HOSPITALS & HEALTH SYSTEMS 192
13.2.1.1 Enterprise analytics integration drives system-wide performance accountability 192
13.2.2 PHYSICIAN GROUPS & CLINICS 193
13.2.2.1 Value-based contracts drive analytics adoption in ambulatory care settings 193
13.2.3 AMBULATORY SURGERY CENTERS 194
13.2.3.1 Operational transparency and quality metrics drive ASC Analytics investment 194
13.2.4 OTHER PROVIDERS 195
13.3 HEALTHCARE PAYERS 196
13.3.1 PRIVATE INSURANCE COMPANIES 198
13.3.1.1 Actuarial intelligence and member analytics sustain commercial plan competitiveness 198
13.3.2 GOVERNMENT PAYERS 199
13.3.2.1 Federal efficiency mandates accelerate analytics in public payer programs 199
13.3.3 OTHER PAYERS 200
13.4 PHARMACIES 202
13.5 OTHER END USERS 203
14 HEALTHCARE ANALYTICS MARKET, BY REGION 205
14.1 INTRODUCTION 206
14.2 NORTH AMERICA 206
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 207
14.2.2 US 215
14.2.2.1 High adoption of electronic health records to drive market 215
14.2.3 CANADA 223
14.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market 223

14.3 EUROPE 230
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 231
14.3.2 GERMANY 238
14.3.2.1 Government initiatives to increase use of analytics in healthcare to drive market 238
14.3.3 UK 245
14.3.3.1 Availability of venture capital investments to drive market 245
14.3.4 FRANCE 252
14.3.4.1 Strong financial support for digital health to augment market 252
14.3.5 ITALY 260
14.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 260
14.3.6 SPAIN 267
14.3.6.1 Growing adoption of personalized medicine to drive market 267
14.3.7 REST OF EUROPE 273
14.4 ASIA PACIFIC 281
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 281
14.4.2 JAPAN 289
14.4.2.1 Rising geriatric population to drive demand for effective patient management solutions 289
14.4.3 CHINA 296
14.4.3.1 Favorable reforms and growing number of electronic health records to aid market growth 296
14.4.4 INDIA 303
14.4.4.1 Favorable government initiatives to fuel market 303
14.4.5 AUSTRALIA 311
14.4.5.1 Strong digital health ecosystem and government-led initiatives to drive healthcare analytics adoption 311
14.4.6 SOUTH KOREA 318
14.4.6.1 Favorable government initiatives and strong digital health ecosystem to fuel market growth 318
14.4.7 REST OF ASIA PACIFIC 326
14.5 LATIN AMERICA 334
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334
14.5.2 BRAZIL 341
14.5.2.1 Growing adoption of digital solutions in healthcare to boost market 341
14.5.3 MEXICO 349
14.5.3.1 Growing prominence of startups and rising R&D activity to propel market 349
14.5.4 REST OF LATIN AMERICA 356
14.6 MIDDLE EAST & AFRICA 363
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 363
14.6.2 GCC COUNTRIES 367
14.6.2.1 Rising investments and developing healthcare infrastructure to drive market 367
14.6.3 SAUDI ARABIA 375
14.6.3.1 Strong government-led digital health transformation to fuel market 375
14.6.4 UAE 382
14.6.4.1 Strong government-led digital health transformation to drive market 382
14.6.5 REST OF GCC COUNTRIES 389
14.6.5.1 Strong government-led digital health transformation to fuel market 389
14.6.6 SOUTH AFRICA 396
14.6.6.1 Favorable government-led digital health transformation and rising disease burden to fuel market 396
14.6.7 REST OF MIDDLE EAST & AFRICA 403
15 COMPETITIVE LANDSCAPE 411
15.1 INTRODUCTION 411
15.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 411
15.3 REVENUE ANALYSIS, 2021–2025 412
15.4 MARKET SHARE ANALYSIS, 2025 413
15.5 BRAND/SOFTWARE COMPARISON 417
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 418
15.6.1 STARS 418
15.6.2 EMERGING LEADERS 418
15.6.3 PERVASIVE PLAYERS 418
15.6.4 PARTICIPANTS 418
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 420
15.6.5.1 Company footprint 420
15.6.5.2 Region footprint 421
15.6.5.3 Component footprint 422
15.6.5.4 Application footprint 423
15.6.5.5 End user footprint 424
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 425
15.7.1 PROGRESSIVE COMPANIES 425
15.7.2 RESPONSIVE COMPANIES 425
15.7.3 DYNAMIC COMPANIES 425
15.7.4 STARTING BLOCKS 425
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 427
15.7.5.1 Detailed list of key startups/SMEs 427
15.7.5.2 Competitive benchmarking of key startups/SMEs 428
15.8 COMPANY VALUATION AND FINANCIAL METRICS 428
15.9 COMPETITIVE SCENARIO 429
15.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 429
15.9.2 DEALS 431
15.9.3 EXPANSIONS 432
16 COMPANY PROFILES 433
16.1 KEY PLAYERS 433
16.1.1 MERATIVE 433
16.1.1.1 Business overview 433
16.1.1.2 Products/Solutions/Services offered 434
16.1.1.3 Recent developments 434
16.1.1.3.1 Product launches/enhancements/approvals 434
16.1.1.3.2 Deals 435
16.1.1.4 MnM view 435
16.1.1.4.1 Right to Win 435
16.1.1.4.2 Strategic choices 436
16.1.1.4.3 Weaknesses and competitive threats 436
16.1.2 SAS INSTITUTE INC. 437
16.1.2.1 Business overview 437
16.1.2.2 Products/Solutions/Services offered 438
16.1.2.3 Recent developments 439
16.1.2.3.1 Product launches/enhancements/approvals 439
16.1.2.4 MnM view 440
16.1.2.4.1 Right to Win 440
16.1.2.4.2 Strategic choices 440
16.1.2.4.3 Weaknesses and competitive threats 441
16.1.3 OPTUM, INC. 442
16.1.3.1 Business overview 442
16.1.3.2 Products/Solutions/Services offered 443
16.1.3.3 Recent developments 445
16.1.3.3.1 Product launches and approvals 445
16.1.3.3.2 Deals 446
16.1.3.4 MnM view 446
16.1.3.4.1 Right to Win 446
16.1.3.4.2 Strategic choices 447
16.1.3.4.3 Weaknesses and competitive threats 447
16.1.4 ORACLE 448
16.1.4.1 Business overview 448
16.1.4.2 Products/Solutions/Services offered 450
16.1.4.3 Recent developments 452
16.1.4.3.1 Product launches/enhancements/approvals 452
16.1.4.3.2 Deals 453
16.1.4.4 MnM view 454
16.1.4.4.1 Right to Win 454
16.1.4.4.2 Strategic choices 454
16.1.4.4.3 Weaknesses and competitive threats 455

16.1.5 HEALTH CATALYST 456
16.1.5.1 Business overview 456
16.1.5.2 Products/Solutions/Services offered 457
16.1.5.3 Recent developments 458
16.1.5.3.1 Product launches/enhancements/approvals 458
16.1.5.3.2 Deals 460
16.1.5.4 MnM view 460
16.1.5.4.1 Right to Win 460
16.1.5.4.2 Strategic choices 461
16.1.5.4.3 Weaknesses and competitive threats 461
16.1.6 EXLSERVICE HOLDINGS, INC. 462
16.1.6.1 Business overview 462
16.1.6.2 Products/Solutions/Services offered 463
16.1.6.3 Recent developments 465
16.1.6.3.1 Deals 465
16.1.6.3.2 Other developments 465
16.1.6.4 MnM view 465
16.1.6.4.1 Right to Win 465
16.1.6.4.2 Strategic choices 466
16.1.6.4.3 Weaknesses and competitive threats 466
16.1.7 VERADIGM LLC 467
16.1.7.1 Business overview 467
16.1.7.2 Products/Solutions/Services offered 469
16.1.7.3 Recent developments 470
16.1.7.3.1 Product launches/enhancements/approvals 470
16.1.7.3.2 Deals 471
16.1.7.3.3 Other developments 472
16.1.7.4 MnM view 472
16.1.7.4.1 Right to Win 472
16.1.7.4.2 Strategic choices 472
16.1.7.4.3 Weaknesses and competitive threats 473
16.1.8 CITIUSTECH INC. 474
16.1.8.1 Business overview 474
16.1.8.2 Products/Solutions/Services offered 475
16.1.8.3 Recent developments 475
16.1.8.3.1 Product launches/enhancements/approvals 475
16.1.8.3.2 Deals 476
16.1.8.3.3 Expansions 476
16.1.9 CVS HEALTH 477
16.1.9.1 Business overview 477
16.1.9.2 Products/Solutions/Services offered 478
16.1.9.3 Recent developments 479
16.1.9.3.1 Product launches/enhancements/approvals 479
16.1.9.3.2 Deals 479
16.1.10 INOVALON 481
16.1.10.1 Business overview 481
16.1.10.2 Products/Solutions/Services offered 482
16.1.10.3 Recent developments 483
16.1.10.3.1 Product launches/enhancements/approvals 483
16.1.10.3.2 Deals 483
16.1.10.3.3 Expansions 484
16.1.10.3.4 Other developments 484
16.1.11 MCKESSON CORPORATION 485
16.1.11.1 Business overview 485
16.1.11.2 Products/Solutions/Services offered 486
16.1.11.3 Recent developments 487
16.1.11.3.1 Deals 487
16.1.12 MEDEANALYTICS, INC. 488
16.1.12.1 Business overview 488
16.1.12.2 Products/Solutions/Services offered 489
16.1.12.3 Recent developments 490
16.1.12.3.1 Deals 490
16.1.13 COTIVITI, INC. 491
16.1.13.1 Business overview 491
16.1.13.2 Products/Solutions/Services offered 492
16.1.14 DATAVANT, INC. 493
16.1.14.1 Business overview 493
16.1.14.2 Products/Solutions/Services offered 494
16.1.14.3 Recent developments 495
16.1.14.3.1 Product launches/enhancements/approvals 495
16.1.14.3.2 Deals 495
16.1.15 DEFINITIVE HEALTHCARE, LLC 497
16.1.15.1 Business overview 497
16.1.15.2 Products/Solutions/Services offered 498
16.1.15.3 Recent developments 499
16.1.15.3.1 Product launches/enhancements/approvals 499
16.1.15.3.2 Deals 500
16.1.16 KOMODO HEALTH, INC. 501
16.1.16.1 Business overview 501
16.1.16.2 Products/Solutions/Services offered 502
16.1.16.3 Recent developments 502
16.1.16.3.1 Product launches/enhancements/approvals 502
16.1.16.3.2 Deals 503

16.1.17 ATHENAHEALTH, INC. 504
16.1.17.1 Business overview 504
16.1.17.2 Products/Solutions/Services offered 505
16.1.17.3 Recent developments 505
16.1.17.3.1 Product launches/enhancements/approvals 505
16.1.17.3.2 Deals 507
16.1.18 IQVIA 508
16.1.18.1 Business overview 508
16.1.18.2 Products/Solutions/Services offered 509
16.1.18.3 Recent developments 510
16.1.18.3.1 Product launches/enhancements/approvals 510
16.1.18.3.2 Deals 511
16.1.19 WIPRO 512
16.1.19.1 Business overview 512
16.1.19.2 Products/Solutions/Services offered 513
16.1.20 CLOUDERA, INC. 514
16.1.20.1 Business overview 514
16.1.20.2 Products/Solutions/Services offered 515
16.1.20.3 Recent developments 516
16.1.20.3.1 Product launches/enhancements/approvals 516
16.1.20.3.2 Deals 517
16.2 OTHER PLAYERS 518
16.2.1 HEALTHVERITY, INC. 518
16.2.2 KYRUUS, INC. 518
16.2.3 HEALTHCORUM 519
16.2.4 LUMA HEALTH INC. 519
16.2.5 VALIDIC, INC. 520
17 RESEARCH METHODOLOGY 521
17.1 RESEARCH APPROACH 521
17.1.1 SECONDARY RESEARCH 522
17.1.1.1 Key data from secondary sources 523
17.1.2 PRIMARY RESEARCH 523
17.1.2.1 Primary sources 524
17.1.2.2 Key data from primary sources 525
17.1.2.3 Breakdown of primary interviews 525
17.1.2.4 Insights from primary experts 526
17.2 RESEARCH METHODOLOGY DESIGN 526
17.3 MARKET SIZE ESTIMATION 527
17.4 DATA TRIANGULATION 532
17.5 RESEARCH ASSUMPTIONS 533
17.6 RESEARCH LIMITATIONS 534
17.6.1 METHODOLOGY-RELATED 534
17.6.2 SCOPE-RELATED 534
17.7 RISK ASSESSMENT 535
18 APPENDIX 536
18.1 DISCUSSION GUIDE 536
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 541
18.3 CUSTOMIZATION OPTIONS 543
18.4 RELATED REPORTS 543
18.5 AUTHOR DETAILS 544

LIST OF TABLES

TABLE 1 USD EXCHANGE RATES 49
TABLE 2 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023–2024 67
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON HEALTHCARE ANALYTICS MARKET 76
TABLE 4 ROLE OF COMPANIES IN ECOSYSTEM 81
TABLE 5 INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 82
TABLE 6 INDICATIVE PRICING OF ANALYTICS SOLUTIONS, BY REGION 84
TABLE 7 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 84
TABLE 8 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS 86
TABLE 9 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT 87
TABLE 10 CLINICAL DECISION-MAKING PROCESS IMPROVEMENT WITH DATA OPERATING SYSTEM PLATFORM 88
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 89
TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE ANALYTICS MARKET 99
TABLE 13 HEALTHCARE ANALYTICS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2015–2026 100
TABLE 14 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 107
TABLE 15 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 108
TABLE 16 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 108
TABLE 17 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE
ANALYTICS MARKET 109
TABLE 18 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 110
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 22 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 113
TABLE 23 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 117
TABLE 25 KEY BUYING CRITERIA, BY END USER 118
TABLE 26 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET 119
TABLE 27 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET 120
TABLE 28 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 123
TABLE 29 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 124
TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 125
TABLE 31 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,
2024–2031 (USD MILLION) 126
TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION,
2024–2031 (USD MILLION) 126
TABLE 33 HEALTHCARE ANALYTICS MARKET FOR ANALYTICS OPERATIONS, BY REGION, 2024–2031 (USD MILLION) 128
TABLE 34 HEALTHCARE ANALYTICS MARKET FOR INFRASTRUCTURE & CLOUD MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 129
TABLE 35 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE,
2024–2031 (USD MILLION) 130
TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2024–2031 (USD MILLION) 130
TABLE 37 HEALTHCARE ANALYTICS MARKET FOR TRAINING & EDUCATION, BY REGION, 2024–2031 (USD MILLION) 131
TABLE 38 HEALTHCARE ANALYTICS MARKET FOR IMPLEMENTATION & INTEGRATION,
BY REGION, 2024–2031 (USD MILLION) 133
TABLE 39 HEALTHCARE ANALYTICS MARKET FOR CONSULTING, BY REGION,
2024–2031 (USD MILLION) 134
TABLE 40 HEALTHCARE ANALYTICS MARKET FOR SUPPORT & MAINTENANCE, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 42 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 137
TABLE 43 HEALTHCARE ANALYTICS MARKET FOR POINT ANALYTICS SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 44 HEALTHCARE ANALYTICS MARKET FOR ENTERPRISE-WIDE ANALYTICS PLATFORMS, BY REGION, 2024–2031 (USD MILLION) 139
TABLE 45 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 141
TABLE 46 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISES, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 47 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED, BY REGION,
2024–2031 (USD MILLION) 143
TABLE 48 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 145
TABLE 49 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 50 APPLICATIONS OF PREDICTIVE ANALYTICS 148
TABLE 51 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS 149
TABLE 52 PREDICTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 53 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS 150
TABLE 54 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 151
TABLE 55 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 152
TABLE 56 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 154
TABLE 57 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS 155
TABLE 58 FINANCIAL ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 155
TABLE 59 FINANCIAL ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 60 COMMERCIALLY AVAILABLE CLAIMS ANALYTICS SOLUTIONS 157
TABLE 61 FINANCIAL ANALYTICS MARKET FOR CLAIMS ANALYTICS, BY REGION,
2024–2031 (USD MILLION) 157
TABLE 62 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS 158
TABLE 63 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 159
TABLE 64 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS 160
TABLE 65 FINANCIAL ANALYTICS MARKET FOR FRAUD, WASTE, AND ABUSE ANALYTICS,
BY REGION, 2024–2031 (USD MILLION) 160
TABLE 66 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS 161
TABLE 67 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & PAYMENT INTEGRITY, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 68 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS 163
TABLE 69 CLINICAL ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163
TABLE 70 CLINICAL ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 71 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL
BENCHMARKING SOLUTIONS 165
TABLE 72 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2024–2031 (USD MILLION) 165
TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT 166
TABLE 74 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2024–2031 (USD MILLION) 167
TABLE 75 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE 168
TABLE 76 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 168
TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS 169
TABLE 78 CLINICAL ANALYTICS MARKET FOR REMOTE PATIENT MONITORING ANALYTICS,
BY REGION, 2024–2031 (USD MILLION) 169
TABLE 79 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD
EVIDENCE SOLUTIONS 170
TABLE 80 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH ANALYTICS,
BY REGION, 2024–2031 (USD MILLION) 171
TABLE 81 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL &
ADMINISTRATIVE ANALYTICS 172
TABLE 82 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 172
TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 172
TABLE 84 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS 173
TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 86 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS 175
TABLE 87 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 175
TABLE 88 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 176
TABLE 89 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR CAPACITY & WORKFLOW ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 177
TABLE 90 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS 178
TABLE 91 POPULATION HEALTH ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178
TABLE 92 POPULATION HEALTH ANALYTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 179
TABLE 93 POPULATION HEALTH ANALYTICS MARKET FOR CHRONIC DISEASE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 94 POPULATION HEALTH ANALYTICS MARKET FOR PREVENTIVE CARE ANALYTICS,
BY REGION, 2024–2031 (USD MILLION) 181
TABLE 95 POPULATION HEALTH ANALYTICS MARKET FOR VALUE-BASED CARE ANALYTICS,
BY REGION, 2024–2031 (USD MILLION) 182
TABLE 96 POPULATION HEALTH ANALYTICS MARKET FOR RISK STRATIFICATION,
BY REGION, 2024–2031 (USD MILLION) 183
TABLE 97 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 184
TABLE 98 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 185
TABLE 99 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT COMMUNICATION & OUTREACH ANALYTICS, BY REGION,
2024–2031 (USD MILLION) 186
TABLE 100 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT ADHERENCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 187
TABLE 101 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT EXPERIENCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 188
TABLE 102 HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 190
TABLE 103 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 191
TABLE 104 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 191
TABLE 105 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & HEALTH SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 193
TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHYSICIAN GROUPS & CLINICS, BY REGION, 2024–2031 (USD MILLION) 194
TABLE 107 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2024–2031 (USD MILLION) 195
TABLE 108 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION,
2024–2031 (USD MILLION) 196
TABLE 109 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 110 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY REGION,
2024–2031 (USD MILLION) 198
TABLE 111 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES,
BY REGION, 2024–2031 (USD MILLION) 199
TABLE 112 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT PAYERS, BY REGION,
2024–2031 (USD MILLION) 200
TABLE 113 HEALTHCARE ANALYTICS MARKET FOR OTHER PAYERS, BY REGION,
2024–2031 (USD MILLION) 201
TABLE 114 HEALTHCARE ANALYTICS MARKET FOR PHARMACIES, BY REGION,
2024–2031 (USD MILLION) 202
TABLE 115 HEALTHCARE ANALYTICS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 204
TABLE 116 HEALTHCARE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 206
TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 208
TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 209
TABLE 119 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 209
TABLE 120 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 209
TABLE 121 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 210
TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 210
TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 210
TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 211
TABLE 126 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 212
TABLE 127 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 212
TABLE 128 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 213
TABLE 129 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 213
TABLE 130 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 214
TABLE 131 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 214
TABLE 132 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 215
TABLE 133 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 215
TABLE 134 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 216
TABLE 135 US: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 217
TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY SERVICE 2024–2031 (USD MILLION) 217
TABLE 137 US: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE
2024–2031 (USD MILLION) 217
TABLE 138 US: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE
2024–2031 (USD MILLION) 218
TABLE 139 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT
2024–2031 (USD MILLION) 218
TABLE 140 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 141 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 219
TABLE 142 US: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 219
TABLE 143 US: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 220
TABLE 144 US: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 220
TABLE 145 US: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 221
TABLE 146 US: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 221
TABLE 147 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 222
TABLE 148 US: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 222
TABLE 149 US: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 222
TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 224
TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 224
TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 224
TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 225
TABLE 154 CANADA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 225
TABLE 155 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 225
TABLE 156 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 157 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 226
TABLE 158 CANADA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 227
TABLE 159 CANADA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 227
TABLE 160 CANADA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 228
TABLE 161 CANADA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 228
TABLE 162 CANADA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 229
TABLE 163 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 229
TABLE 164 CANADA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 230
TABLE 165 CANADA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 230
TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 232
TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 232
TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 232
TABLE 169 EUROPE: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 233
TABLE 170 EUROPE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 233
TABLE 171 EUROPE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 233
TABLE 172 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 234
TABLE 173 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 174 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 234
TABLE 175 EUROPE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 235
TABLE 176 EUROPE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 235
TABLE 177 EUROPE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 236
TABLE 178 EUROPE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 236
TABLE 179 EUROPE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 237
TABLE 180 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 237
TABLE 181 EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 238
TABLE 182 EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 238
TABLE 183 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 239
TABLE 184 GERMANY: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 239
TABLE 185 GERMANY: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 240
TABLE 186 GERMANY: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 240
TABLE 187 GERMANY: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 240
TABLE 188 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 241
TABLE 189 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 190 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 241
TABLE 191 GERMANY: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 242
TABLE 192 GERMANY: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 242
TABLE 193 GERMANY: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 243
TABLE 194 GERMANY: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 243
TABLE 195 GERMANY: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 244
TABLE 196 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 244
TABLE 197 GERMANY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 245
TABLE 198 GERMANY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 245
TABLE 199 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 246
TABLE 200 UK: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 246
TABLE 201 UK: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 247
TABLE 202 UK: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 247
TABLE 203 UK: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 247
TABLE 204 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 248
TABLE 205 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 206 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 248
TABLE 207 UK: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 249
TABLE 208 UK: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 249
TABLE 209 UK: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 250
TABLE 210 UK: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 250
TABLE 211 UK: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 251
TABLE 212 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 251
TABLE 213 UK: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 252
TABLE 214 UK: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 252
TABLE 215 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 253
TABLE 216 FRANCE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 253
TABLE 217 FRANCE: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 254
TABLE 218 FRANCE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 254
TABLE 219 FRANCE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 254
TABLE 220 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 255
TABLE 221 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 222 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 256
TABLE 223 FRANCE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 256
TABLE 224 FRANCE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 257
TABLE 225 FRANCE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 257
TABLE 226 FRANCE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 258
TABLE 227 FRANCE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 258
TABLE 228 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 259
TABLE 229 FRANCE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 259
TABLE 230 FRANCE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 259
TABLE 231 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 260
TABLE 232 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT FOR SOFTWARE,
2024–2031 (USD MILLION) 261
TABLE 233 ITALY: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 261
TABLE 234 ITALY: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 261
TABLE 235 ITALY: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 262
TABLE 236 ITALY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 262
TABLE 237 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 238 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 263
TABLE 239 ITALY: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 263
TABLE 240 ITALY: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 264
TABLE 241 ITALY: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 264
TABLE 242 ITALY: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 265
TABLE 243 ITALY: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 265
TABLE 244 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 266
TABLE 245 ITALY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 266
TABLE 246 ITALY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 266
TABLE 247 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 267
TABLE 248 SPAIN: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 267
TABLE 249 SPAIN: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 268
TABLE 250 SPAIN: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 268
TABLE 251 SPAIN: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 268
TABLE 252 SPAIN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 269
TABLE 253 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 254 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 269
TABLE 255 SPAIN: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 270
TABLE 256 SPAIN: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 270
TABLE 257 SPAIN: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 271
TABLE 258 SPAIN: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 271
TABLE 259 SPAIN: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 272
TABLE 260 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 272
TABLE 261 SPAIN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 273
TABLE 262 SPAIN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 273
TABLE 263 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 274
TABLE 264 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 274
TABLE 265 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 274
TABLE 266 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 275
TABLE 267 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 275
TABLE 268 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 275
TABLE 269 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 270 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 276
TABLE 271 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 277
TABLE 272 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 277
TABLE 273 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 278
TABLE 274 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 278
TABLE 275 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 279
TABLE 276 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 279
TABLE 277 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 280
TABLE 278 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 280
TABLE 279 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 283
TABLE 280 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 283
TABLE 281 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 283
TABLE 282 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 284
TABLE 283 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 284
TABLE 284 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 284
TABLE 285 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 285
TABLE 286 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 285
TABLE 287 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 285
TABLE 288 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 286
TABLE 289 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 286
TABLE 290 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 287
TABLE 291 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 287
TABLE 292 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 288
TABLE 293 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 288
TABLE 294 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 289
TABLE 295 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 289
TABLE 296 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 290
TABLE 297 JAPAN: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 290
TABLE 298 JAPAN: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 290
TABLE 299 JAPAN: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 291
TABLE 300 JAPAN: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 291
TABLE 301 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 291
TABLE 302 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE 2024–2031 (USD MILLION) 292
TABLE 303 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 292
TABLE 304 JAPAN: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 293
TABLE 305 JAPAN: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 293
TABLE 306 JAPAN: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 294
TABLE 307 JAPAN: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 294
TABLE 308 JAPAN: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 295
TABLE 309 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 295
TABLE 310 JAPAN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 296
TABLE 311 JAPAN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 296
TABLE 312 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 297
TABLE 313 CHINA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 297
TABLE 314 CHINA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 298
TABLE 315 CHINA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 298
TABLE 316 CHINA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 298
TABLE 317 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 299
TABLE 318 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 319 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 299
TABLE 320 CHINA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 300
TABLE 321 CHINA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 300
TABLE 322 CHINA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 301
TABLE 323 CHINA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 301
TABLE 324 CHINA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 302
TABLE 325 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 302
TABLE 326 CHINA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 303
TABLE 327 CHINA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 303
TABLE 328 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 304
TABLE 329 INDIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 305
TABLE 330 INDIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 305
TABLE 331 INDIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 305
TABLE 332 INDIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 306
TABLE 333 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 306
TABLE 334 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 335 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 307
TABLE 336 INDIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 307
TABLE 337 INDIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 308
TABLE 338 INDIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 308
TABLE 339 INDIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 309
TABLE 340 INDIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 309
TABLE 341 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 310
TABLE 342 INDIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 310
TABLE 343 INDIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 310
TABLE 344 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 312
TABLE 345 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 312
TABLE 346 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 312
TABLE 347 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 313
TABLE 348 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 313
TABLE 349 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 313
TABLE 350 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 314
TABLE 351 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 314
TABLE 352 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 315
TABLE 353 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 315
TABLE 354 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 316
TABLE 355 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 316
TABLE 356 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 317
TABLE 357 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 317
TABLE 358 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 318
TABLE 359 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 318
TABLE 360 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 320
TABLE 361 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 320
TABLE 362 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 320
TABLE 363 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 321
TABLE 364 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 321
TABLE 365 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 321
TABLE 366 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 367 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 322
TABLE 368 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 323
TABLE 369 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 323
TABLE 370 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 324
TABLE 371 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 324
TABLE 372 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 325
TABLE 373 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 325
TABLE 374 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 326
TABLE 375 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 326
TABLE 376 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 327
TABLE 377 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 327
TABLE 378 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 328
TABLE 379 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 328
TABLE 380 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 328
TABLE 381 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 329
TABLE 382 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 329
TABLE 383 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 329
TABLE 384 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 330
TABLE 385 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 330
TABLE 386 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 331
TABLE 387 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 331
TABLE 388 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 332
TABLE 389 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 332
TABLE 390 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 333
TABLE 391 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 333
TABLE 392 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 335
TABLE 393 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 335
TABLE 394 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 335
TABLE 395 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 336
TABLE 396 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 336
TABLE 397 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 336
TABLE 398 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 337
TABLE 399 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 337
TABLE 400 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 337
TABLE 401 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 338
TABLE 402 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 338
TABLE 403 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 339
TABLE 404 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 339
TABLE 405 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 340
TABLE 406 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 340
TABLE 407 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 341
TABLE 408 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 341
TABLE 409 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 342
TABLE 410 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 343
TABLE 411 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 343
TABLE 412 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 343
TABLE 413 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 344
TABLE 414 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 344
TABLE 415 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 416 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 345
TABLE 417 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 345
TABLE 418 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 346
TABLE 419 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 346
TABLE 420 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 347
TABLE 421 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 347
TABLE 422 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 348
TABLE 423 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 348
TABLE 424 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 348
TABLE 425 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 349
TABLE 426 MEXICO: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 350
TABLE 427 MEXICO: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 350
TABLE 428 MEXICO: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 350
TABLE 429 MEXICO: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 351
TABLE 430 MEXICO: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 351
TABLE 431 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 351
TABLE 432 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 352
TABLE 433 MEXICO: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 352
TABLE 434 MEXICO: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 353
TABLE 435 MEXICO: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 353
TABLE 436 MEXICO: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 354
TABLE 437 MEXICO: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 354
TABLE 438 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 355
TABLE 439 MEXICO: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 355
TABLE 440 MEXICO: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 355
TABLE 441 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 356
TABLE 442 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 357
TABLE 443 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 357
TABLE 444 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 357
TABLE 445 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 358
TABLE 446 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 358
TABLE 447 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 358
TABLE 448 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 359
TABLE 449 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 359
TABLE 450 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 360
TABLE 451 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 360
TABLE 452 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 361
TABLE 453 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 361
TABLE 454 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 362
TABLE 455 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 362
TABLE 456 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 362
TABLE 457 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 364
TABLE 458 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 364
TABLE 459 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 365
TABLE 460 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 365
TABLE 461 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 365
TABLE 462 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 366
TABLE 463 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 366
TABLE 464 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 366
TABLE 465 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 367
TABLE 466 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 367
TABLE 467 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 368
TABLE 468 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 368
TABLE 469 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 369
TABLE 470 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 369
TABLE 471 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 369
TABLE 472 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 370
TABLE 473 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 370
TABLE 474 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 370
TABLE 475 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 371
TABLE 476 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 371
TABLE 477 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 372
TABLE 478 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 372
TABLE 479 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 373
TABLE 480 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 373
TABLE 481 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 374
TABLE 482 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 374
TABLE 483 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 374
TABLE 484 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 375
TABLE 485 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 376
TABLE 486 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 376
TABLE 487 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 376
TABLE 488 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 377
TABLE 489 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 377
TABLE 490 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 377
TABLE 491 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 378
TABLE 492 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 378
TABLE 493 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 379
TABLE 494 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 379
TABLE 495 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 380
TABLE 496 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 380
TABLE 497 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 381
TABLE 498 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 381
TABLE 499 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 381
TABLE 500 UAE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 382
TABLE 501 UAE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 383
TABLE 502 UAE: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 383
TABLE 503 UAE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 383
TABLE 504 UAE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE,
2024–2031 (USD MILLION) 384
TABLE 505 UAE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 384
TABLE 506 UAE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 384
TABLE 507 UAE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 385
TABLE 508 UAE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS,
2024–2031 (USD MILLION) 385
TABLE 509 UAE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 386
TABLE 510 UAE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 386
TABLE 511 UAE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 387
TABLE 512 UAE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 387
TABLE 513 UAE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 388
TABLE 514 UAE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER,
2024–2031 (USD MILLION) 388
TABLE 515 UAE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 388
TABLE 516 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 390
TABLE 517 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 390
TABLE 518 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 390
TABLE 519 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 391
TABLE 520 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 391
TABLE 521 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 391
TABLE 522 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 392
TABLE 523 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392
TABLE 524 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 393
TABLE 525 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 393
TABLE 526 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 394
TABLE 527 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 394
TABLE 528 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 395
TABLE 529 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 395
TABLE 530 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 396
TABLE 531 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 396
TABLE 532 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 397
TABLE 533 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE,
2024–2031 (USD MILLION) 397
TABLE 534 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE,
2024–2031 (USD MILLION) 398
TABLE 535 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE,
2024–2031 (USD MILLION) 398
TABLE 536 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 398
TABLE 537 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 399
TABLE 538 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2024–2031 (USD MILLION) 399
TABLE 539 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 399
TABLE 540 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 400
TABLE 541 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS,
2024–2031 (USD MILLION) 400
TABLE 542 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 401
TABLE 543 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 401
TABLE 544 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 402
TABLE 545 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2024–2031 (USD MILLION) 402
TABLE 546 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 403
TABLE 547 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER,
2024–2031 (USD MILLION) 403
TABLE 548 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 404
TABLE 549 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY SOFTWARE, 2024–2031 (USD MILLION) 404
TABLE 550 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY SERVICE, 2024–2031 (USD MILLION) 404
TABLE 551 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY MANAGED SERVICE, 2024–2031 (USD MILLION) 405
TABLE 552 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 405
TABLE 553 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 405
TABLE 554 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 406
TABLE 555 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 406
TABLE 556 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 407
TABLE 557 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 407
TABLE 558 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 408
TABLE 559 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 408
TABLE 560 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 409
TABLE 561 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY END USER, 2024–2031 (USD MILLION) 409
TABLE 562 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 410
TABLE 563 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 410
TABLE 564 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
HEALTHCARE ANALYTICS MARKET, 2023–MAY 2026 411
TABLE 565 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION 414
TABLE 566 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT 421
TABLE 567 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT 422
TABLE 568 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT 423
TABLE 569 HEALTHCARE ANALYTICS MARKET: END USER FOOTPRINT 424
TABLE 570 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES 427
TABLE 571 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 428
TABLE 572 HEALTHCARE ANALYTICS MARKET: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS, 2023–MAY 2026 429
TABLE 573 HEALTHCARE ANALYTICS MARKET: DEALS, 2023–MAY 2026 431
TABLE 574 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, 2023–MAY 2026 432
TABLE 575 MERATIVE: COMPANY OVERVIEW 433
TABLE 576 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 434
TABLE 577 MERATIVE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 434
TABLE 578 MERATIVE: DEALS 435
TABLE 579 SAS INSTITUTE INC.: COMPANY OVERVIEW 437
TABLE 580 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 438
TABLE 581 SAS INSTITUTE INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 439
TABLE 582 OPTUM, INC.: COMPANY OVERVIEW 442
TABLE 583 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 443
TABLE 584 OPTUM, INC.: PRODUCT LAUNCHES AND APPROVALS 445
TABLE 585 OPTUM, INC.: DEALS 446
TABLE 586 ORACLE: COMPANY OVERVIEW 448
TABLE 587 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 450
TABLE 588 ORACLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 452
TABLE 589 ORACLE: DEALS 453
TABLE 590 HEALTH CATALYST: COMPANY OVERVIEW 456
TABLE 591 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED 457
TABLE 592 HEALTH CATALYST: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 458
TABLE 593 HEALTH CATALYST: DEALS 460
TABLE 594 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 462
TABLE 595 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 463
TABLE 596 EXLSERVICE HOLDINGS, INC.: DEALS 465
TABLE 597 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS 465
TABLE 598 VERADIGM LLC: COMPANY OVERVIEW 468
TABLE 599 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 469
TABLE 600 VERADIGM LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 470
TABLE 601 VERADIGM LLC: DEALS 471
TABLE 602 VERADIGM LLC: OTHER DEVELOPMENTS 472
TABLE 603 CITIUSTECH INC.: COMPANY OVERVIEW 474
TABLE 604 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 475
TABLE 605 CITIUSTECH INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 475
TABLE 606 CITIUSTECH INC.: DEALS 476
TABLE 607 CITIUSTECH INC.: EXPANSIONS 476
TABLE 608 CVS HEALTH: COMPANY OVERVIEW 477
TABLE 609 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 478
TABLE 610 CVS HEALTH: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 479
TABLE 611 CVS HEALTH: DEALS 479
TABLE 612 INOVALON: COMPANY OVERVIEW 481
TABLE 613 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 482
TABLE 614 INOVALON: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 483
TABLE 615 INOVALON: DEALS 483
TABLE 616 INOVALON: EXPANSIONS 484
TABLE 617 INOVALON: OTHER DEVELOPMENTS 484
TABLE 618 MCKESSON CORPORATION: COMPANY OVERVIEW 485
TABLE 619 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 486
TABLE 620 MCKESSON CORPORATION: DEALS 487
TABLE 621 MEDEANALYTICS, INC.: COMPANY OVERVIEW 488
TABLE 622 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 489
TABLE 623 MEDEANALYTICS, INC.: DEALS 490
TABLE 624 COTIVITI, INC.: COMPANY OVERVIEW 491
TABLE 625 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 492
TABLE 626 DATAVANT INC.: COMPANY OVERVIEW 493
TABLE 627 DATAVANT INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 494
TABLE 628 DATAVANT INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 495
TABLE 629 DATAVANT INC.: DEALS 495
TABLE 630 DEFINITIVE HEALTHCARE, LLC: COMPANY OVERVIEW 497
TABLE 631 DEFINITIVE HEALTHCARE, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 498
TABLE 632 DEFINITIVE HEALTHCARE, LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 499
TABLE 633 DEFINITIVE HEALTHCARE, LLC.: DEALS 500
TABLE 634 KOMODO HEALTH, INC.: COMPANY OVERVIEW 501
TABLE 635 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 502
TABLE 636 KOMODO HEALTH, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 502
TABLE 637 KOMODO HEALTH, INC.: DEALS 503
TABLE 638 ATHENAHEALTH, INC.: COMPANY OVERVIEW 504
TABLE 639 ATHENAHEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 505
TABLE 640 ATHENAHEALTH, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 505
TABLE 641 ATHENAHEALTH, INC.: DEALS 507
TABLE 642 IQVIA: COMPANY OVERVIEW 508
TABLE 643 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 509
TABLE 644 IQVIA: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 510
TABLE 645 IQVIA: DEALS 511
TABLE 646 WIPRO: COMPANY OVERVIEW 512
TABLE 647 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 513
TABLE 648 CLOUDERA, INC.: COMPANY OVERVIEW 514
TABLE 649 CLOUDERA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 515
TABLE 650 CLOUDERA, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 516
TABLE 651 CLOUDERA, INC.: DEALS 517
TABLE 652 HEALTHVERITY, INC.: COMPANY OVERVIEW 518
TABLE 653 KYRUUS, INC.: COMPANY OVERVIEW 518
TABLE 654 HEALTHCORUM: COMPANY OVERVIEW 519
TABLE 655 LUMA HEALTH INC.: COMPANY OVERVIEW 519
TABLE 656 VALIDIC, INC.: COMPANY OVERVIEW 520

LIST OF FIGURES

FIGURE 1 MARKET SCENARIO 51
FIGURE 2 HEALTHCARE ANALYTICS MARKET, 2024–2031 52
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN
HEALTHCARE ANALYTICS MARKET 52
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE ANALYTICS MARKET 53
FIGURE 5 HIGH-GROWTH SEGMENTS IN HEALTHCARE ANALYTICS MARKET 54
FIGURE 6 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 55
FIGURE 7 EXPANSION OF DECENTRALIZED AND REMOTE PATIENT-CENTRIC TRIALS TO DRIVE MARKET 56
FIGURE 8 HEALTHCARE PROVIDERS AND US ACCOUNTED FOR LARGEST MARKET
SHARES IN 2025 57
FIGURE 9 JAPAN TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 58
FIGURE 10 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
FIGURE 11 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS, 2009–2023 65
FIGURE 12 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023 66
FIGURE 13 HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 75
FIGURE 14 HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 79
FIGURE 15 HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 85
FIGURE 18 PATENT PUBLICATION TRENDS IN HEALTHCARE ANALYTICS MARKET, 2015–2026 98
FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE
ANALYTICS MARKET 98
FIGURE 20 APPLIED AND GRANTED PATENTS IN HEALTHCARE ANALYTICS MARKET, JANUARY 2015–FEBRUARY 2026 99
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 116
FIGURE 22 KEY BUYING CRITERIA, BY END USER 117
FIGURE 23 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT 208
FIGURE 24 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT 282
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 413
FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 414
FIGURE 27 BRAND/SOFTWARE COMPARISON 417
FIGURE 28 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 419
FIGURE 29 HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT 420
FIGURE 30 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 426
FIGURE 31 FINANCIAL METRICS (EV/EBITDA) 428
FIGURE 32 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK
BETA OF KEY VENDORS 429
FIGURE 33 OPTUM, INC.: COMPANY SNAPSHOT (2025) 443
FIGURE 34 ORACLE: COMPANY SNAPSHOT (2024) 449
FIGURE 35 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 457
FIGURE 36 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2025) 463
FIGURE 37 VERADIGM LLC: COMPANY SNAPSHOT (2022) 468
FIGURE 38 CVS HEALTH: COMPANY SNAPSHOT (2025) 478
FIGURE 39 MCKESSON CORPORATION: COMPANY SNAPSHOT (2025) 486
FIGURE 40 DEFINITIVE HEALTHCARE, LLC: COMPANY SNAPSHOT (2025) 498
FIGURE 41 IQVIA: COMPANY SNAPSHOT (2025) 509
FIGURE 42 WIPRO: COMPANY SNAPSHOT (2025) 513
FIGURE 43 RESEARCH DESIGN 521
FIGURE 44 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 527
FIGURE 45 BOTTOM-UP APPROACH 528
FIGURE 46 TOP-DOWN APPROACH 529
FIGURE 47 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 530
FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 530
FIGURE 49 DATA TRIANGULATION 533

---

---